This action is responsible for the inhibition of insulin secretion following cytokine treatment of islets and is the basis for the belief that cytokines participate in, or mediate, the loss of functional β-cell mass during diabetes development (5, 18). The gene discussed is INS; the disease is diabetes mellitus.